Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2861-2867

  Heinrich, Tilman ^a   Heidt, Hartmut ^a   Hafner, Verena ^a   Schmidt Gayk, Heinrich ^b   Jenetzky, Ekkehart ^a   Walter Sack, Ingeborg ^a   Mikus, Gerd ^a   Bommer, Jürgen ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Limbach Laboratory   (Germany)

^c Heimdialyse   (Germany)

Author keywords

Calcium carbonate; Calcium load; Serum calcium; Sevelamer; Urinary calcium excretion

Indexed keywords

CALCIUM; CALCIUM CARBONATE; CHLORIDE; DREISACARB; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; SEVELAMER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM URINE LEVEL; CHLORIDE URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FLATULENCE; HUMAN; HUMAN EXPERIMENT; INTESTINE ABSORPTION; KIDNEY FUNCTION; MAGNESIUM URINE LEVEL; MALE; NAUSEA; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; URINARY EXCRETION;

ADULT; ANTACIDS; CALCIUM; CALCIUM CARBONATE; CHELATING AGENTS; CREATININE; CROSS-OVER STUDIES; HUMANS; INTESTINAL ABSORPTION; KIDNEY; MAGNESIUM; MALE; POLYAMINES; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 52449127970     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn151     Document Type: Article

References (15)

1. Silver J, Kilav R, Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2002; 283: F367-F376
2. Nolan CR, Qunibi WY. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis. Kidney Int Suppl 2005; 95: S13-S20
3. Bellasi A, Kooienga L, Block GA. Phosphate binders: new products and challenges. Hemodial Int 2006; 10: 225-234
4. Campean V, Neureiter D, Varga I et al. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res 2005; 28: 280-289
5. Asmus HG, Braun J, Krause R et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 2005; 20: 1653-1661
6. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824
7. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
8. Scopacasa F, Wishart JM, Horowitz M et al. Relation between calcium absorption and serum calcitriol in normal men: evidence for age-related intestinal resistance to calcitriol. Eur J Clin Nutr 2004; 58: 264-269
9. Wildermuth S, Dittrich K, Schmidt-Gayk H et al. Scintillation proximity assay for calcitriol in serum without high pressure liquid chromatography. Clin Chim Acta 1993; 220: 61-70
10. Pannemans DL, Schaafsma G, Westerterp KR. Calcium excretion, apparent calcium absorption and calcium balance in young and elderly subjects: influence of protein intake. Br J Nutr 1997; 77: 721-729
11. Braun J, Asmus HG, Holzer H et al. Long-term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification. Clin Nephrol. 2004; 62: 104-115
12. National Kidney Foundation. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1-201
13. Graziani G, Badalamenti S, Como G et al. Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron 2002; 91: 474-479
14. De Santo NG, Frangiosa A, Anastasio P et al. Sevelamer worsens metabolic acidosis in hemodialysis patients. J Nephrol 2006; 19 (Suppl 9): S108-S114
15. Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441